Induction of ovulation with cyclophenyl.

Area of Science:

• Reproductive Endocrinology
• Pharmacology

Background:

• Anovulation and menstrual irregularities like amenorrhea and oligomenorrhea are common causes of female infertility.
• Effective ovulation induction therapies are crucial for improving fertility outcomes.

Purpose of the Study:

• To evaluate the efficacy of Cyclophenyl in treating infertility associated with amenorrhea, oligomenorrhea, and persistent anovulation.
• To determine the success rates of Cyclophenyl across different patient subgroups based on menstrual cycle history and estradiol levels.

Main Methods:

• A retrospective analysis of 495 treatment cycles using Cyclophenyl in 286 women with ovulation disorders.
• Data collected included patient diagnosis, plasma estradiol levels, and treatment outcomes (ovulatory cycles, infertility resolution).

Main Results:

• The overall success rate for inducing ovulatory cycles was 58% (288/495 cycles).
• Cyclophenyl resolved infertility in 43% of cases (61 women).
• Success rates varied significantly: 15-18% for prolonged/short-term amenorrhea with low estradiol (<50 pg/ml), 43-68% for amenorrhea with higher estradiol (>50 pg/ml), and 72% for oligomenorrhea/anovulation.

Conclusions:

• Cyclophenyl is an effective treatment for infertility due to ovulation disorders, particularly in cases of oligomenorrhea and persistent anovulation.
• Patient characteristics, specifically estradiol levels and the type of menstrual irregularity, influence treatment success rates.
• Higher plasma estradiol levels are associated with better outcomes in amenorrheic patients treated with Cyclophenyl.